Concord Biotech Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Sep '24
Jun '24
Mar '24
Dec '23
Sep '23
Total Qtr Revenue cr
320.21
226.11
329.78
248.98
270.47
Other Income Qtr Cr10.0310.3110.818.198.13
Operating Revenues Qtr310.18215.80318.97240.80262.35

*All values are in Cr.

Operating Expenses Qtr
173.50
134.52
184.68
134.87
143.16
Operating Profit Qtr
136.68
81.28
134.29
105.93
119.19
EBIDT Qtr Cr
146.70
91.59
145.10
114.12
127.32
Depreciation Qtr
13.31
13.18
13.72
13.54
13.30
Net Profit Qtr
95.74
59.59
95.02
77.57
81.02
Basic EPS Qtr
9.15
5.70
9.08
7.41
7.74
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -